The Lancet

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in ...

aDepartment of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA bDepartment of Obstetrics, Gynecology ...